Stocks Tumbling on Lethargic Results: Hecla Mining Company (NYSE:HL), B2Gold Corp. (NYSE:BTG)

Hecla Mining Company (NYSE:HL) runs in leading trade, it moving down -7.82% to traded at $5.42. HL attains analyst recommendation of 3.00 on scale of 1-5 with week’s performance of -8.13%.

Hecla Mining Company (NYSE:HL) recognized its miners, past and present, on National Miner’s Day, Tuesday, December 6, 2016. “I want to thank the more than 10,000 hardworking men and women who have been part of the Hecla team over the past 125 years on National Miner’s Day,” said Phillips S. Baker, Jr., Hecla’s President and CEO. “Together, through good times and bad, we have built Hecla to become the largest primary silver producer and the third-largest producer of lead and zinc, in the USA. These achievements create jobs for our miners and value for our shareholders.”

To find out the technical position of HL, it holds price to book ratio of 1.56 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. It has forward price to earnings ratio of 17.55. HL is presenting price to cash flow of 12.77 and free cash flow concluded as 71.20.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -584.40%, and looking further price to next year’s EPS is 77.25%. While take a short look on price to sales ratio, that was 4.11.

B2Gold Corp. (NYSE:BTG) kept active in under and overvalue discussion, BTG holds price to book ratio of 1.52 that presents much better indicator to find market price of a share price over its book value of equity for investment valuation.

Fundament/ News Factor in Focus

Taking look on ratio analysis, BTG has forward price to earnings ratio of 20.45. other hand, keeping in mind stable cash flows but few growth prospects make traders to value lower. The firm has price volatility of 5.51% for a week and 4.99% for a month. Narrow down four to firm performance, its weekly performance was -11.42% and monthly performance was -5.86%.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *